Morning Overview on MSN
Cancer’s most notorious protein MYC also quietly repairs tumor DNA damage — blocking the trick could make chemotherapy far deadlier to cells it targets
For decades, oncologists have watched a frustrating pattern repeat itself. Tumors fueled by the MYC protein, one of the most ...
A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against ...
MedPage Today on MSN
GLP-1s linked to lower risk of cancer spread in four tumor types
Accumulating evidence of possible benefit warrants randomized trials, experts say ...
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
New research from Peter Mac has uncovered why some parts of the brain may be more vulnerable to tumor growth than others, ...
UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...
A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...
A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key ...
Cancer is a health condition in which cells grow uncontrollably, whereas a tumor is an abnormal mass of tissue that develops when cells multiply too quickly. Healthcare professionals may also refer to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results